Just to clarify, the EU does in fact approve GMO traits, biotech traits. There are a number of concerns that Canada and other countries have with respect to trying to export to the EU. One has to do with their approval process. On paper they do approve or welcome biotech traits, but it's a very long approval process and it doesn't always follow the script, if you will.
One of the things the Canadian government worked on quite closely with the European Commission was to gain commitments that both the commission and Canada would work together to try to ensure that the approval processes for biotech trades were efficient and really honour the processes that both governments have in place.
In terms of what happens when you can get the product into the market, we have a number of challenges. One is that EU consumers just seem to be uninterested in consuming products that are derived from biotech products. We buy canola oil at the grocery store that comes from Canadian canola. Most likely it is made from or blended with product that was genetically modified. We don't see the consumer market in Europe as a viable commercial market for our products.
There is, though, quite a bit of opportunity to export canola oil to the EU for their biofuels industry. Under the CETA right now there's a 3% tariff on oils, canola oil, and that will go to zero right away, so that's where we see probably about $90 million in potential.
There are also concerns with a low-level presence, as you know. Because grains and oilseed products are shipped in bulk around the world, even though containers are cleaned, if you have a very small—like one in 10,000—particle of a biotech product mixed in with, let's say, a corn shipment, it becomes a problem. Again, the European Commission has agreed to work with Canada to try to find ways to alleviate the tensions around low-level presence.